Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma

This study is collecting information about gene mutations (specific DNA changes) in lymphoma patients to understand how these abnormalities relate to disease characteristics and outcomes, with the goal of improving future treatments. **You may be eligible if:** - You have been diagnosed with any type of lymphoma (according to WHO 2017 classification) - Your life expectancy is at least 3 months - You are willing to sign an informed consent form **You may NOT be eligible if:** - You have a history of another active cancer or a different malignancy currently requiring treatment - The study researchers determine you are unsuitable for other reasons Talk to your doctor to see if this trial is right for you.